luzindole has been researched along with ramelteon in 6 studies
Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (ramelteon) | Trials (ramelteon) | Recent Studies (post-2010) (ramelteon) |
---|---|---|---|---|---|
265 | 1 | 119 | 317 | 59 | 204 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cecon, E; Jockers, R; Rivara, S; Witt-Enderby, PA; Zlotos, DP | 1 |
Davidson, K; Eleutheriades, A; Sugden, D; Tsotinis, A | 1 |
Imbesi, M; Manev, H; Uz, T | 1 |
Heymann, P; Kubulus, D; Mathes, AM; Rensing, H; Waibel, L; Weiler, J; Wolf, B | 1 |
Fink, T; Glas, M; Kiefer, D; Kleber, A; Mathes, AM; Rensing, H; Reus, E; Volk, T; Wolf, A; Wolf, B; Wolff, M | 1 |
Hirai, K; Nishiyama, K | 1 |
6 other study(ies) available for luzindole and ramelteon
Article | Year |
---|---|
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
Topics: Animals; Binding Sites; Depressive Disorder; Humans; Ligands; Melatonin; Models, Molecular; Protein Multimerization; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship | 2014 |
Design and synthesis of new N1 and C3-substituted 4-fluoroindolic melatoninergics.
Topics: Animals; Chromatography; Drug Design; Humans; Indenes; Indoles; Iodine Radioisotopes; Mass Spectrometry; Melanophores; Melatonin; Mice; Molecular Structure; NIH 3T3 Cells; Protein Binding; Radioligand Assay; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Transition Temperature; Tryptamines; Xenopus laevis | 2007 |
Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Topics: Animals; Animals, Newborn; Cells, Cultured; Cerebellum; Enzyme Activation; Indenes; Mice; Mice, Inbred C3H; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Tetrahydronaphthalenes; Tryptamines | 2008 |
Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Indenes; Infusions, Intravenous; Liver Circulation; Liver Diseases; Liver Function Tests; Male; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Melatonin; Sensitivity and Specificity; Shock, Hemorrhagic; Tryptamines | 2008 |
Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Indenes; Interleukin-10; Interleukin-6; Male; Melatonin; Mice; Mice, Inbred C3H; Mice, Knockout; Rats; Rats, Sprague-Dawley; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Receptors, Melatonin; Sepsis; Tryptamines; Tumor Necrosis Factor-alpha | 2014 |
The melatonin agonist ramelteon induces duration-dependent clock gene expression through cAMP signaling in pancreatic INS-1 β-cells.
Topics: Animals; ARNTL Transcription Factors; Cell Line; Colforsin; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Humans; Indenes; Insulin-Secreting Cells; Nuclear Receptor Subfamily 1, Group D, Member 1; Phosphorylation; Rats; Receptors, Melatonin; Tryptamines | 2014 |